Current Management
Learn about the current strategies for the management of IgAN and the ongoing need for therapies that target the underlying causes of IgAN. Hear more from our experts: References: Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Video
Urgency to Treat
Explore how early detection and diagnosis of IgAN can support timely treatment and help reduce the risk of disease progression. Hear more from our experts: Reference: Read MorePathophysiology
Explore the role of APRIL in B-cell development and IgAN pathogenesis, and learn how a better understanding of IgAN pathophysiology allows for a more targeted management approach. Hear more from… Read MoreDisease Burden
Discover how the burden of IgAN, including the likelihood of progression to kidney failure within 10–15 years, can significantly affect patients’ mental and emotional well-being. Hear more from our experts:… Read MoreKey Messages from KDIGO IgAN Experts (2025)
These videos are part of a three-part series featuring IgA Nephropathy (IgAN) experts and Work Group Members of the forthcoming KDIGO 2025 IgAN Guideline Update sharing key insights on emerging… Read MoreKey Takeaways for Clinicians from the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, & Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
This is the first guideline from KDIGO on a rare kidney disease, and provides healthcare providers, stakeholders, and people living with ADPKD with practical tools to improve diagnosis, care, and… Read MoreUnderstanding the Benefits & Risks of Corticosteroid Use in Patients with IgA Nephropathy (IgAN) (Infographic Video)
Corticosteroids may be considered, with caution, for patients with IgAN at high risk of progression, according to the 2021 KDIGO guidelines. Read MoreUpdates in IgA Nephropathy
Learn the latest advancements in the understanding and management of IgA Nephropathy (IgAN) with two expert-led videos sponsored by Otsuka with Professors Brad Rovin, MD (United States) and Jürgen Floege,… Read MoreNephU Community Advisor Highlight – Dr Ankur Shah
Learn about how Community Advisor Dr Ankur Shah entered the Nephrology field! Read MoreMechanism Of Disease: Immunoglobulin A Nephropathy (IgAN)
Learn about the pathogenesis of Immunoglobulin A Nephropathy (IgAN). Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
